Said Essa Abdallah, Alaa Eldeen Nouh Mohammed, Mohammed Ghaniam Naglaa, Graham David Y, Said Sabry Hany
Department of Tropical Medicine and Biochemistry Department, Minofyia University, Minofyia, Egypt.
Scand J Infect Dis. 2008;40(9):730-3. doi: 10.1080/00365540802023725.
Helicobacter pylori infection, peptic ulcer and gastric cancer are common problems in Egypt. We investigated the prevalence of cagA-positive Helicobacter pylori infections among Egyptian adults in relation to presentation (e.g. dyspepsia vs asymptomatic controls) in Minofyia, Egypt. Patients included men or women seeking care for at least 3 months of upper gastrointestinal symptoms. Helicobacter pylori status was determined by rapid urease test and gastric histopathology in patients and by anti-Helicobacter pylori IgG antibodies in controls. CagA status was determined using an anti-cag A ELISA. 99 Helicobacter pylori infected patients were entered including 90 dyspeptic patients (30 each with gastric cancer, peptic ulcer, and non-ulcer dyspepsia) and 9 non-dyspeptic healthy controls. Age ranged from 27 to 78 y (mean 49.5 y); 50% were men. Anti-cagA antibodies were present in 62.2% of dyspeptic patients compared with 11% of asymptomatic controls (p = 0.004). Anti-cagA antibodies were more prevalent among dyspeptic patients with gastric cancer or peptic ulcer (73.3%) compared to those with non-ulcer dyspepsia (40%) (p = 0.004). The prevalence of cagA in Egypt was related to the clinical presentation of Helicobacter pylori infection being lowest in asymptomatic controls (11.1%) and increasingly prevalent in non-ulcer dyspepsia (40%), peptic ulcer (66.7%), and gastric cancer (89%).
幽门螺杆菌感染、消化性溃疡和胃癌是埃及常见的问题。我们调查了埃及米努菲亚地区成年人群中细胞毒素相关基因A(cagA)阳性幽门螺杆菌感染的患病率,并将其与临床表现(如消化不良与无症状对照)相关联。患者包括有至少3个月上消化道症状并寻求治疗的男性或女性。通过快速尿素酶试验和胃组织病理学确定患者的幽门螺杆菌感染状况,通过检测对照人群中抗幽门螺杆菌IgG抗体来确定感染状况。使用抗cagA酶联免疫吸附测定法(ELISA)确定cagA状态。纳入了99例幽门螺杆菌感染患者,其中包括90例消化不良患者(分别为30例胃癌、消化性溃疡和非溃疡性消化不良患者)和9例无消化不良症状的健康对照。年龄范围为27至78岁(平均49.5岁);50%为男性。62.2%的消化不良患者存在抗cagA抗体,而无症状对照人群中这一比例为11%(p = 0.004)。与非溃疡性消化不良患者(40%)相比,胃癌或消化性溃疡的消化不良患者中抗cagA抗体更为普遍(73.3%)(p = 0.004)。埃及cagA的患病率与幽门螺杆菌感染的临床表现相关,在无症状对照人群中最低(11.1%),在非溃疡性消化不良(40%)、消化性溃疡(66.7%)和胃癌(89%)患者中患病率逐渐升高。